CBMT-05. GENETIC AND EPIGENETIC MECHANISMS REGULATING SCD INHIBITOR SENSITIVITY IN GLIOBLASTOMA

A status-quo in targeted cancer therapy is that out of the thousands of somatic alterations found in a cancer cell, alterations only in driver genes determine therapeutic strategy. Despite unimpressive results of some driver-targeted therapies, and given that the majority of genomic alterations in c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Oatman, Nicole, Dasgupta, Nupur, Dasgupta, Biplab, Choi, Kwangmin, Gawali, Mruniya, Gupta, Nishtha, Parameswaran, Sreeja, Lawler, Sean, Brennan, Cameron, Wu, Jianqiang, Sallans, Larry, Desai, Pankaj, Weirauch, Matthew, Komurov, Kakajan
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Cell Biology and Metabolism
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847859/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.127
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados